DUBLIN–(BUSINESS WIRE)–The “Diabetic Macular Edema (DME): Epidemiology Forecast to 2034” report has been added to ResearchAndMarkets.com’s offering. In the 7MM, the diagnosed prevalent cases of DME in diabetes are expected to increase from 2,888,125 …
Author: Business Wire
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
GENEVA–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-a…
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
GENEVA–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-a…
17-Year-Old Young Tissue Recipient and 14 Tissue Donors to Share the Healing Power of Cornea and Tissue Donation at the 2026 OneLegacy Donate Life Rose Parade® Float
AZUSA, Calif.–(BUSINESS WIRE)–A 17-year-old high school junior from Pomeroy, WA and 14 cornea and tissue donors will be honored on the 2026 OneLegacy Donate Life float, Treasure Every Moment Together, as part of the iconic Rose Parade® on New Year’s …
La FDA autorise la première lentille de contact à profondeur de champ étendue pour la presbytie
BOCA RATON, Floride–(BUSINESS WIRE)–Cataltheia Group et sa filiale américaine Bruno Vision Care LLC, leader dans le domaine de l’innovation en matière de santé oculaire, ont annoncé aujourd’hui que la Food and Drug Administration (FDA) américaine ava…
L'FDA approva le prime lenti a contatto con profondità di focalizzazione estesa per la presbiopia
BOCA RATON, Fla.–(BUSINESS WIRE)–The Cataltheia Group e la sua controllata, Bruno Vision Care LLC, azienda leader nell’innovazione della salute degli occhi, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha approvato la pri…
La FDA autoriza la primera lente de contacto con profundidad de foco extendida para la presbicia
BOCA RATÓN, Florida–(BUSINESS WIRE)–Cataltheia Group y su filial en los Estados Unidos, Bruno Vision Care LLC, líder en innovación en salud ocular, anunciaron hoy que la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) ha autori…
FDA keurt eerste Extended Depth of Focus-contactlens voor presbyopie goed
BOCA RATON, Fla.–(BUSINESS WIRE)–De Cataltheia Group en Bruno Vision Care LLC, de Amerikaanse dochteronderneming van het bedrijf en leider op gebied van innovatie voor de gezondheid van de ogen, maakten vandaag bekend dat de Amerikaanse FDA (U.S. Foo…
FDA genehmigt erste Kontaktlinse mit erweiterter Tiefenschärfe für Presbyopie
BOCA RATON, Fla.–(BUSINESS WIRE)–Die Cataltheia Group und ihre US-Tochtergesellschaft Bruno Vision Care LLC, ein führendes Unternehmen im Bereich der Augenheilkunde, gaben heute bekannt, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Dru…
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia
BOCA RATON, Fla.–(BUSINESS WIRE)–The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable …
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and…
GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the U.S…
GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies Targeting Orbital Fibroblasts Drive Revenue Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Thyroid Eye Disease Treatments Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. The thyroid eye disease treatments market is undergoing substantial transformation, fueled by n…
Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today responded to the fourth po…
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to require STAAR t…
Ollin Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases, today announced that Jason Ehrlich, M.D., Ph.D….
Bausch + Lomb Announces Two Board of Directors Appointments
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Eduardo C. Alfonso, MD, and Steven H. Collis have been appoin…
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…